On Wednesday, in a significant development drugmaker Pfizer Inc said, all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance will be made available at not-for-profit prices to 45 of the world’s poorest countries. The bouquet… Read More ›
In a statement Pfizer Inc said, it is recalling some batches of blood pressure drug Accuretic and two authorized cheaper versions of the drug citing the presence of elevated levels of a nitrosamine, a potential carcinogenic. Pfizer said it has not received… Read More ›
On Tuesday, investors hope to learn Pfizer Inc’s plans for what could be a once in a generation cash infusion from COVID-19 treatments and vaccines in 2022. Some drugmakers are looking to spend on potential acquisitions. According to Chief Executive Albert… Read More ›
On Wednesday, in a statement Pfizer Inc said, it has decided to stop producing biosimilar products in China; it has also decided to sell one of its business unit in the eastern city of Hangzhou to WuXi Biologics Inc. “The… Read More ›
In a significant development that marks an attempt to go back to pre-coronavirus pandemic times, officials from Israel said they plan to reopen restaurants around March 9 and restart tourism with Cyprus as part of a gradual return to normality… Read More ›
The first batch of COVID-19 vaccines has arrived in Canada said Canadian Prime Minister Justin Trudeau. Canadians are likely to roll up their sleeves to take a shot as early as later today. “The first batch of doses of Pfizer-BioNTech’s… Read More ›
In a statement, Brazil’s health ministry said, it will be signing a non-binding letters of intent to buy coronavirus vaccines from four companies as well as from Russia’s sovereign wealth fund; these purchases will be subject to the approval of… Read More ›
According to early data analysis of stock trading, news of a breakthrough in the race to find a vaccine for COVID-19 triggered one of the heaviest trading days since the height of the pandemic crisis with trade worth around $2… Read More ›
On Wednesday, in a statement, CStone Pharmaceuticals stated, a unit of Pfizer Inc has agreed to acquire a 9.9% stake in it for $200 million (HK$1.55 billion). With the news reaching the market the shares of the Hong Kong-listed biopharmaceutical… Read More ›
In a statement, the U.S. Department of Justice stated, Gilead Sciences Inc has agreed to settle allegations that it improperly used the Caring Voice Coalition as a conduit to cover thousands of patients’ co-payment obligations and has agreed to pay… Read More ›
manageria.biz 